“Stephanie was an outstanding communicator and was a great resource during my interview process. I ended up getting the job that I wanted largely in part to her efforts. Thanks!”
About
With over 25 years of experience in the biotech, pharmaceutical, and medical sales…
Activity
-
Novo Nordisk is taking another step to expand access to our innovative medicines by lowering the self-pay price for GLP-1 treatments and launching…
Novo Nordisk is taking another step to expand access to our innovative medicines by lowering the self-pay price for GLP-1 treatments and launching…
Liked by Stephanie Rudd
-
Today, we announced that longer-term results from our Phase 3 study of our investigational gene therapy for patients with Glycogen Storage Disease…
Today, we announced that longer-term results from our Phase 3 study of our investigational gene therapy for patients with Glycogen Storage Disease…
Liked by Stephanie Rudd
-
Coming home to where my story began… This wasn’t just another work award trip—it was the trip of a lifetime. I got to choose anywhere in the world…
Coming home to where my story began… This wasn’t just another work award trip—it was the trip of a lifetime. I got to choose anywhere in the world…
Liked by Stephanie Rudd
Experience & Education
Recommendations received
1 person has recommended Stephanie
Join now to viewMore activity by Stephanie
-
Completing enrollment for the Phase 3 Aspire study marks a crucial step forward in addressing the urgent need for effective treatments and better…
Completing enrollment for the Phase 3 Aspire study marks a crucial step forward in addressing the urgent need for effective treatments and better…
Liked by Stephanie Rudd
-
We are proud to share that our colleagues in Global Business Service (GBS) center in Bangalore have been awarded the GCC Workplace Award in the…
We are proud to share that our colleagues in Global Business Service (GBS) center in Bangalore have been awarded the GCC Workplace Award in the…
Liked by Stephanie Rudd
-
The FDA granted Breakthrough Therapy Designation to our investigational therapy GTX-102. This is a significant milestone that supports our work to…
The FDA granted Breakthrough Therapy Designation to our investigational therapy GTX-102. This is a significant milestone that supports our work to…
Liked by Stephanie Rudd
-
We have completed the closing of our merger with GlycoMimetics and previously announced $200M financing. Crescent will begin trading today on Nasdaq…
We have completed the closing of our merger with GlycoMimetics and previously announced $200M financing. Crescent will begin trading today on Nasdaq…
Liked by Stephanie Rudd
-
I am both proud and excited to share we will be expanding to a 3rd location with Nordstrom this fall at their Bellevue Square store. As two…
I am both proud and excited to share we will be expanding to a 3rd location with Nordstrom this fall at their Bellevue Square store. As two…
Liked by Stephanie Rudd
-
Pretty proud of this young lady who happens to be my talented daughter! Can’t wait to see you anchoring the 9pm in Wichita, Bella! Congratulations…
Pretty proud of this young lady who happens to be my talented daughter! Can’t wait to see you anchoring the 9pm in Wichita, Bella! Congratulations…
Liked by Stephanie Rudd
-
A true giant on lysosomal diseases and a great friend and colleague.
A true giant on lysosomal diseases and a great friend and colleague.
Liked by Stephanie Rudd
-
Discover the charm of Los Altos, known for its tree-lined streets, top-rated schools, and close-knit community. Whether you're looking for a…
Discover the charm of Los Altos, known for its tree-lined streets, top-rated schools, and close-knit community. Whether you're looking for a…
Liked by Stephanie Rudd
Other similar profiles
-
Ben Lovelace
Ben Lovelace
-
Joe McClung
Joe McClung
-
Rick Snowden, CDR
Rick Snowden, CDR
-
Debra Duggan
Debra Duggan
-
Tim Jadwin, CPC
Tim Jadwin, CPC
-
Andy Jacobs
Andy Jacobs
-
Susan (Adler) McSweeney
Susan (Adler) McSweeney
-
Dave Cormell
Dave Cormell
Explore top content on LinkedIn
Find curated posts and insights for relevant topics all in one place.
View top content